These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 13219069)

  • 1. [Studies on problems of virulence and resistance of tubercle bacterial strains from pulmonary tuberculosis patients after chemotherapy].
    GIERHAKE FW
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1954; 112(4):283-92. PubMed ID: 13219069
    [No Abstract]   [Full Text] [Related]  

  • 2. The fate of tubercle bacilli in vivo.
    HOBBY GL
    Am J Med; 1955 May; 18(5):753-63. PubMed ID: 14361459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the number and virulence of tubercle bacilli isolated form pulmonary tuberculosis during short course chemotherapy].
    Chen SH
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Oct; 13(5):286-8, 318. PubMed ID: 2128212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of action of anti-tubercular antibiotics and chemotherapy].
    MANNETTI C
    Arch Maragliano Patol Clin; 1954; 9(4):819-62. PubMed ID: 13208391
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE EXCRETION OF VISIBLE, BUT NON-VIABLE TUBERCLE BACTERIA DURING CHEMOTHERAPY OF CAVERNOUS PULMONARY TUBERCULOSIS].
    BARTMANN K; SCHUETZ I; VIETINGHOFF-SCHEEL OE
    Prax Pneumol; 1964 May; 18():273-87. PubMed ID: 14213747
    [No Abstract]   [Full Text] [Related]  

  • 6. The treated pulmonary lesion and its tubercle bacillus. II. The death and resurrection.
    VANDIVIERE HM; LORING WE; MELVIN I; WILLIS S
    Am J Med Sci; 1956 Jul; 232(1):30-7; passim. PubMed ID: 13326887
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical problems in chemotherapy of tuberculosis].
    SIMROCK W; ARNDT T
    Arzneimittelforschung; 1953 Jan; 3(1):52. PubMed ID: 13066336
    [No Abstract]   [Full Text] [Related]  

  • 8. [The clinical value of Mycobacterium tuberculosis with different biological properties].
    Vishnevskiĭ BI; Ivanova LA; Kolechko NG; Kochanova NK; Makovskaia GM
    Probl Tuberk; 1991; (4):51-4. PubMed ID: 1906617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the virulence in the guinea pig of tuberculosis bacilli isolated from patients with pulmonary tuberculosis before treatment in Shanghai].
    Yang DY
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Feb; 12(1):15-7, 61. PubMed ID: 2500258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary tuberculosis caused by Mycobacterium tuberculosis of different genotypes].
    Sapozhnikova NV; Skvortsova LA; Pavlova MV; Vishnevskiĭ BI; Otten TF; Vasil'eva SN; Manicheva OA; Mokrousov IV; Narvskaia OV
    Probl Tuberk Bolezn Legk; 2003; (10):13-5. PubMed ID: 14669621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary tuberculosis: trends in chemotherapy and antibiotic therapy.
    ANDERSON HR
    J Tn State Med Assoc; 1955 Jan; 48(1):6-10. PubMed ID: 13222470
    [No Abstract]   [Full Text] [Related]  

  • 12. [MICROBIOLOGICAL FINDINGS IN CHRONIC PULMONARY TUBERCULOSIS].
    DIPERNA A; MICELI S
    Arch Tisiol Mal Appar Respir; 1964 Aug; 19():603-25. PubMed ID: 14253921
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy and the tuberculosis bacillus].
    BOJALIL LF
    Rev Mex Tuberc Enferm Apar Respir; 1956; 17(1):19-24. PubMed ID: 24544200
    [No Abstract]   [Full Text] [Related]  

  • 14. Catalase activity studies: a screening program for chemotherapy failures in tuberculosis treatment.
    SALIBA NA
    J Ky Med Assoc; 1959 Oct; 57():1196-9. PubMed ID: 14440999
    [No Abstract]   [Full Text] [Related]  

  • 15. [Administration of viomycin in pulmonary tuberculosis caused by streptomycin and hydrazide resistant Mycobacterium tuberculosis].
    SPROVIERI L; ZUBIANI M
    G Ital Della Tuberc; 1956; 10(3):172-6. PubMed ID: 13345011
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current incidence of resistance to isoniazid and its practical effects on the immediate and remote results of therapy of pulmonary tuberculosis].
    TACQUET A; VOISIN C; FOURNIER P; SERGEANT YH
    Rev Tuberc; 1958; 22(5-6):506-17. PubMed ID: 13591984
    [No Abstract]   [Full Text] [Related]  

  • 17. PhoP, a key player in Mycobacterium tuberculosis virulence.
    Ryndak M; Wang S; Smith I
    Trends Microbiol; 2008 Nov; 16(11):528-34. PubMed ID: 18835713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitivity and resistance of Mycobacterium tuberculosis before and during isoniazid therapy].
    BUNGER P; LASS A
    Z Tuberk; 1953; 103(4-5):202-10. PubMed ID: 14374995
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current drug therapy of pulmonary tuberculosis].
    KRAAN JK
    Ned Tijdschr Geneeskd; 1954 Oct; 98(43):3062-8. PubMed ID: 13223839
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs.
    Palanisamy GS; DuTeau N; Eisenach KD; Cave DM; Theus SA; Kreiswirth BN; Basaraba RJ; Orme IM
    Tuberculosis (Edinb); 2009 May; 89(3):203-9. PubMed ID: 19251482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.